Thrombophilic Mutations Test

A genetic test that screens for hereditary mutations associated with an increased predisposition to blood clots (thrombophilia). It is frequently chosen by people considering or using hormonal contraception, those with a family history of clotting, or anyone wanting to understand their inherited clotting risk. Self-pay with no referral — book and pay online, attend a collection point, receive a genetic results report.

AGELLAB's thrombophilic mutations test examines inherited genetic variants linked to an increased tendency to form blood clots. Because these are germline genetic variants, the test is performed once and the result does not change over a lifetime. It is commonly requested by people who are about to start, or are already using, hormonal contraception — which itself modestly raises clotting risk — as well as by those with a personal or family history of deep-vein thrombosis or pulmonary embolism who want to understand their inherited contribution to that risk. Knowing one's hereditary thrombophilia status can inform conversations with a clinician about contraception choices, pregnancy planning, and precautions around situations of elevated clotting risk such as long-haul travel or surgery. As with any genetic risk marker, a positive result indicates predisposition rather than certainty, and interpretation alongside a physician or genetic specialist is recommended. The analysis is carried out in AGEL-group laboratories accredited to ISO 15189, drawing on the network's dedicated medical-genetics capability. The test is fully self-pay and consumer-facing: clients choose it in the AGELLAB e-shop, reserve a slot and pay online, then attend the Ostrava-Vítkovice collection point or any nationwide collection point for the blood draw. No fasting is required, and the genetic results report is delivered after laboratory processing.